Dermal Fillers And Botulinum Toxin Market
Dermal Fillers and Botulinum Toxin Market: Hyaluronic Acid Based Dermal Fillers Projected to be the Second Most Lucrative Segment by Product Type: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027
- 2017-08-24
- REP-GB-4733
- 220 pages
-
An Incisive, In-depth Analysis on the Dermal Fillers And Botulinum Toxin Market
This study offers a comprehensive, 360 degree analysis on the Dermal Fillers And Botulinum Toxin market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Dermal Fillers And Botulinum Toxin market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Celebrity endorsements and consumer market are an important growth driver
Several dermatology association members i.e. service providers and clinics have seen an increased uptake of aesthetic procedures in the year 2016. The American Academy of Facial Plastic and Reconstructive Surgery estimates that more than 80% of surgeons believed a celebrity endorsement played a vital role in the patient being willing to go under the knife and undergo treatment. The most common procedures are the application of botilinum toxin leading to wrinkle reduction by way of volume restoration. Social and mainstream media have also had an outsized impact on the customer psyche, influencing them to start these treatments early to avoid the onset of ageing or delay it as much as possible.
Rising preference for non-invasive surgical procedures across the globe
The demand for minimally invasive cosmetic treatment, a phenomenon seen worldwide, is poised to benefit the Dermal Fillers and Botulinum Toxin Market. Dermatologists prefer to treat skin diseases through less invasive procedures or topical applications in place of surgical methods. The non-surgical procedures that witnessed a dramatic spike in popularity in 2016 were dermal fillers with hyaluronic acid and botulinum toxin. Injectable treatments are chosen because of greater awareness of measurable improvement in procedures and more information dissemination.
Hyaluronic Acid and Botulinum Toxin key in dermal fillers and botulinum toxin market
Botulinum Toxin is the largest segment in the Dermal Fillers and Botulinum Toxin Market by product type and is larger than the other two segments combined. It is expected to push past US$ 5 Bn by the end of the forecast period making it imperative for key stakeholders in the Dermal Fillers and Botulinum Toxin Market to target. However, the Hyaluronic Acid segment is anticipated to witness a high CAGR of 8.5% from 2017-2027, which companies would do well to take note of while devising their Hyaluronic Acid Dermal Fillers and Botulinum Toxin Market strategies.The Botulinum Toxin segment dominated the global Dermal Fillers and Botulinum Toxin market by product type in terms of revenue in 2017, and this trend is projected to continue throughout the forecast period. Botulinum Toxin is the most attractive segment, with a market attractiveness index of 1.6 over the forecast period.
Inadequate professional training serious concern in the dermal fillers and botulinum toxin market
The treatments are sometimes administered incorrectly to patients and this can lead to serious complications with extremely adverse side-effects. Fillers are injected around the temple region of the head to even out fine lines and reduce crow’s feet. Patients could experience symptoms such as swelling, fever, and extreme pain within two days, especially if the injection punctures a facial vein during the process of administration. These unfortunate accidents would need patients to be administered a dose of antibiotics or steroids that have their own additional side-effects. At present, a limited number of medical institutions offer the required advanced training and this is a particular problem in resource-starved, poorer countries in the world where such treatments are more of a luxury only enjoyed by the privileged few.
High cost a major restraint in the dermal fillers and botulinum toxin market
The cost of botolinum toxin treatments is on the higher side and multiple sessions are necessary to achieve the desired results. The surgeon or physician cost alone is approximately half the cost in the case of dermal fillers; and fillers such as HA, PLLA, CaHA last for a maximum period of two years. Most of them are naturally occurring in the body and they get degraded quickly, which is why multiple sessions are needed, thereby driving up the cost of treatment substantially. Frequent visits to the surgeon or physician is the norm that could potentially stifle the growth prospects of the global Dermal Fillers and Botulinum Toxin Market.
Report Introduction
Customers worldwide are increasingly opting for aesthetic procedures and treatments to look younger than their age suggests. The proliferation of qualified plastic surgeons and their well-established networks play a major role in the dermal fillers and botulinum toxin market. Future Market Insights has released a new report titled ‘Dermal Fillers and Botulinum Toxin Market: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027’ that is an exhaustive analysis of the dermal fillers and botulinum toxin market on the basis of key parameters such as Y-o-Y growth, CAGR, and absolute dollar opportunity.
The global dermal fillers and botulinum toxin market has been studied on the basis of seven key geographic regions viz. North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and MEA. The dermal fillers and botulinum toxin market report devotes an equal amount of attention to both developed and emerging regions by focussing on the drivers, restraints, opportunities and threats that exist in the regional dermal fillers and botulinum toxin market. The historical market size of the largest countries in every region has been compared and contrasted with the anticipated future growth so that key stakeholders in the dermal fillers and botulinum toxin market can gain a clear understanding. The market attractiveness analysis on the basis of the taxonomy concludes this section of the dermal fillers and botulinum toxin market report.
The dermal fillers and botulinum toxin market report begins with the executive summary that is concise and comprehensive. The section includes an overview comprising macroeconomic factors, important facts, and the revenue share by both product type and application. Our experts have analysed the dermal fillers and botulinum toxin market extensively and made their recommendations that you would be highly recommended to take into consideration while devising your long-term market strategies. The recommendations take the form of an overall market approach, segment and region to target with a differentiating strategy to race past your competition in the dermal fillers and botulinum toxin market.
The dermal fillers and botulinum toxin market introduction chapter follows the executive summary and should ideally be read in tandem with it. This section gives readers a grassroots level understanding of the dermal fillers and botulinum toxin market by way of the definition as well as the taxonomy of the dermal fillers and botulinum toxin market.
Dermal Fillers and Botulinum Toxin Market: Taxonomy
|
Region |
Application |
Product Type |
|---|---|---|
|
|
|
The pressure to look younger and fitter has never been more acute than in the 21st century. Key players actively involved in the dermal fillers and botulinum toxin market are more than willing to cater to this demand and are offering a diverse suite of products and services. As a new entrant seeking to enter the dermal fillers and botulinum toxin market or an incumbent who wishes to change your go-to- market strategy, you would do well to understand what your immediate rivals are planning in the dermal fillers and botulinum toxin market. The competition dashboard features some of the companies operating in the dermal fillers and botulinum toxin market by highlighting the key financials, revenue growth, operating and net margin, key ratios, and industry classification codes. A SWOT analysis, recent developments and a broad company strategy outline are highlighted in this section.
Research Methodology
The research methodology adopted by Future Market Insights is considered to be a benchmark in the industry. Our team of diverse and knowledgeable experts have years of experience and they put this to good use during their primary and secondary research in the dermal fillers and botulinum toxin market. They prepare a questionnaire that enables them to gather all the relevant information pertaining to the dermal fillers and botulinum toxin market. The facts are thoroughly scrutinised with the help of the triangulation method and the report data is finally validated using advanced company tools to deliver the required insights pertaining to the dermal fillers and botulinum toxin market.
Dermal Fillers And Botulinum Toxin Market Reports - Table of Contents
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
18. Assumptions and Acronyms Used
19. Research Methodology
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.